Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages

Science Signaling

Volumn 1, Issue 51, 2008, Pages

  Heller, Nicola M ^a   Qi, Xiulan ^a   Junttila, Ilkka S ^b   Shirey, Kari Ann ^a   Vogel, Stefanie N ^a   Paul, William E ^b   Keegan, Achsah D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 13; INTERLEUKIN 4 RECEPTOR TYPE I; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; HUMAN; MACROPHAGE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL LINE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTERLEUKIN-13; MACROPHAGES; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-4, TYPE I; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 58749092367     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.1164795     Document Type: Article

References (89)

1. J. L. Boulay, W. E. Paul, The interleukin-4 family of lymphokines. Curr. Opin. Immunol. 4, 294-298 (1992).
2. S. R. Sprang, J. F. Bazan, Cytokine structural taxonomy and mechanisms of receptor engagement. Curr. Opin. Struct. Biol. 3, 815-827 (1993).
3. D. A. Rozwarski, A. M. Gronenborn, G. M. Clore, J. F. Bazan, A. Bohm, A. Wlodawer, M. Hatada, P. A. Karplus, Structural comparisons among the short-chain helical cytokines. Structure 2, 159-173 (1994).
4. A. Minty, P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, D. Caput, Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248-250 (1993).
5. P. Chomarat, J. Banchereau, Interleukin-4 and interleukin-13: Their similarities and discrepancies. Int. Rev. Immunol. 17, 1-52 (1998).
6. T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, R. L. Coffman, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
7. K. Nelms, A. D. Keegan, J. Zamorano, J. J. Ryan, W. E. Paul, The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738 (1999).
8. E. A. Sabin, M. A. Kopf, E. J. Pearce, Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184, 1871-1878 (1996).
9. C. A. Rumbley, H. Sugaya, S. A. Zekavat, M. El Refaei, P. J. Perrin, S. M. Phillips, Activated eosinophils are the major source of Th2-Associated cytokines in the schistosome granuloma. J. Immunol. 162, 1003-1009 (1999).
10. G. Woerly, N. Roger, S. Loiseau, M. Capron, Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int. Arch. Allergy Immunol. 118, 95-97 (1999).
11. C. Bandeira-Melo, J. C. Hall, J. F. Penrose, P. F. Weller, Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J. Allergy Clin. Immunol. 109, 975-979 (2002).
12. E. A. Jacobsen, A. G. Taranova, N. A. Lee, J. J. Lee, Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation? J. Allergy Clin. Immunol. 119, 1313-1320 (2007).
13. K. A. Shirey, L. E. Cole, A. D. Keegan, S. N. Vogel, Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181, 4159-4167 (2008).
14. M. Wills-Karp, M. Chiaramonte, Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9, 21-27 (2003).
15. S. L. LaPorte, Z. S. Juo, J. Vaclavikova, L. A. Colf, X. Qi, N. M. Heller, A. D. Keegan, K. C. Garcia, Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132, 259-272 (2008).
16. A. L. Andrews, J. W. Holloway, S. T. Holgate, D. E. Davies, IL-4 receptor a is an important modulator of IL-4 and IL-13 receptor binding: Implications for the development of therapeutic targets. J. Immunol. 176, 7456-7461 (2006).
17. K. Kawakami, J. Taguchi, T. Murata, R. K. Puri, The interleukin-13 receptor a2 chain: An essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 97, 2673-2679 (2001).
18. S. Fichtner-Feigl, W. Strober, K. Kawakami, R. K. Puri, A. Kitani, IL-13 signaling through the IL-13a2 receptor is involved in induction of TGF-b1 production and fibrosis. Nat. Med. 12, 99-106 (2006).
19. M. Boothby, A. L. Mora, L. M. Stephenson, Lymphokine-dependent proliferation of T-lymphoid cells: Regulated responsiveness and role in vivo. Crit. Rev. Immunol. 21, 487-522 (2001).
20. A. B. Pernis, P. B. Rothman, JAK-STAT signaling in asthma. J. Clin. Invest. 109, 1279-1283 (2002).
21. A. E. Kelly-Welch, E. M. Hanson, M. R. Boothby, A. D. Keegan, Interleukin-4 and interleukin-13 signaling connections maps. Science 300, 1527-1528 (2003).
22. A. D. Keegan, J. A. Johnston, P. J. Tortolani, L. J. McReynolds, C. Kinzer, J. J. O'Shea, W. E. Paul, Similarities and differences in signal transduction by interleukin 4 and interleukin 13: Analysis of Janus kinase activation. Proc. Natl. Acad. Sci. U.S.A. 92, 7681-7685 (1995).
23. J. Zhu, L. Guo, C. J. Watson, J. Hu-Li, W. E. Paul, Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166, 7276-7281 (2001).
24. A. L. Wurster, D. J. Withers, T. Uchida, M. F. White, M. J. Grusby, Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol. Cell. Biol. 22, 117-126 (2002).
25. F. Blaeser, P. J. Bryce, N. Ho, V. Raman, F. Dedeoglu, D. D. Donaldson, R. S. Geha, H. C. Oettgen, T. A. Chatila, Targeted inactivation of the IL-4 receptor a chain I4R motif promotes allergic airway inflammation. J. Exp. Med. 198, 1189-1200 (2003).
26. I. S. Junttila, K. Mizukami, H. Dickensheets, M. Meier-Schellersheim, H. Yamane, R. P. Donnelly, W. E. Paul, Tuning sensitivity to IL-4 and IL-13: Differential expression of IL-4Ra, IL-13Ra1 and gc regulates relative cytokine sensitivity. J. Exp. Med. 205, 2595-2608 (2008).
27. T. Kreider, R. M. Anthony, J. F. Urban Jr., W. C. Gause, Alternatively activated macrophages in helminth infections. Curr. Opin. Immunol. 19, 448-453 (2007).
28. P. H. Hart, C. S. Bonder, J. Balogh, H. L. Dickensheets, N. Vazquez, K. V. Davies, J. J. Finlay-Jones, R. P. Donnelly, Diminished responses to IL-13 by human monocytes differentiated in vitro: Role of the IL-13Ra1 chain and STAT6. Eur. J. Immunol. 29, 2087-2097 (1999).
29. A. Andersson, S. M. Grunewald, A. Duschl, A. Fischer, J. P. DiSanto, Mouse macrophage development in the absence of the common g chain: Defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur. J. Immunol. 27, 1762-1768 (1997).
30. M. Kornmann, H. Maruyama, U. Bergmann, P. Tangvoranuntakul, H. G. Beger, M. F.White, M. Korc, Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res. 58, 4250-4254 (1998).
31. J. Zamorano, A. E. Kelly, J. Austrian, H. Y. Wang, A. D. Keegan, Costimulation of resting B lymphocytes alters the IL-4-Activated IRS2 signaling pathway in a STAT6 independent manner: Implications for cell survival and proliferation. Cell Res. 11, 44-54 (2001).
32. J. L. Moreno, M. Kaczmarek, A. D. Keegan, M. Tondravi, IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: Irreversible inhibition of the differentiation program activated by RANKL. Blood 102, 1078-1086 (2003).
33. X. J. Sun, L. M. Wang, Y. Zhang, L. Yenush, M. G. Myers Jr., E. Glasheen, W. S. Lane, J. H. Pierce, M. F. White, Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177 (1995).
34. X. J. Sun, D. L. Crimmins, M. G. Myers Jr., M. Miralpeix, M. F. White, Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13, 7418-7428 (1993).
35. E. Y. Skolnik, C. H. Lee, A. Batzer, L. M. Vicentini, M. Zhou, R. Daly, M. J. Myers Jr., J. M. Backer, A. Ullrich, M. F. White, J. Schlessinger, The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling. EMBO J. 12, 1929-1936 (1993).
36. S. Sugimoto, T. J. Wandless, S. E. Shoelson, B. G. Neel, C. T. Walsh, Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosinecontaining peptides derived from insulin receptor substrate-1. J. Biol. Chem. 269, 13614-13622 (1994).
37. M. G. Myers Jr., L. M. Wang, X. J. Sun, Y. Zhang, L. Yenush, J. Schlessinger, J. H. Pierce,M. F. White, Role of IRS-1-GRB-2 complexes in insulin signaling. Mol. Cell. Biol. 14, 3577-3587 (1994).
38. W. Pruett, Y. Yuan, E. Rose, A. G. Batzer, N. Harada, E. Y. Skolnik, Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: Implications for Ras activation by insulin. Mol. Cell. Biol. 15, 1778-1785 (1995).
39. M. J. Welham, V. Duronio, J. W. Schrader, Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. J. Biol. Chem. 269, 5865-5873 (1994).
40. I. N. Foltz, J. C. Lee, P. R. Young, J. W. Schrader, Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-Activated protein kinase pathway. J. Biol. Chem. 272, 3296-3301 (1997).
41. I. N. Foltz, J. W. Schrader, Activation of the stress-Activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89, 3092-3096 (1997).
42. A. E. Hunt, L. M. Williams, F. V. Lali, B. M. Foxwell, IL-4 regulation of p38 MAPK signalling is dependent on cell type. Cytokine 18, 295-303 (2002).
43. S. Canfield, Y. Lee, A. Schröder, P. Rothman, Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J. Immunol. 174, 2494-2498 (2005).
44. D. M. Mosser, The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212 (2003).
45. T. O. Chan, S. E. Rittenhouse, P. N. Tsichlis, AKT/PKB and other D3 phosphoinositideregulated kinases: Kinase activation by phosphoinositide- dependent phosphorylation. Annu. Rev. Biochem. 68, 965-1014 (1999).
46. E. M. Sale, G. J. Sale, Protein kinase B: Signalling roles and therapeutic targeting. Cell. Mol. Life Sci. 65, 113-127 (2008).
47. M. Dancescu, M. Rubio-Trujillo, G. Biron, D. Bron, G. Delespesse, M. Sarfati, Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J. Exp. Med. 176, 1319-1326 (1992).
48. V. A. Illera, C. E. Perandones, L. L. Stunz, D. A. Mower Jr., R. F. Ashman, Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151, 2965-2973 (1993).
49. J. Zamorano, H. Y. Wang, L. M. Wang, J. H. Pierce, A. D. Keegan, IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157, 4926-4934 (1996).
50. G. B. Carey, E. Semenova, X. Qi, A. D. Keegan, IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: Contribution of the PI-3 kinase/AKT pathway. Cell Res. 17, 942-955 (2007).
51. M. A. Berry, D. Parker, N. Neale, L. Woodman, A. Morgan, P. Monk, P. Bradding, A. J. Wardlaw, I. D. Pavord, C. E. Brightling, Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 114, 1106-1109 (2004).
52. S. K. Huang, H. Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, M. C. Liu, IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155, 2688-2694 (1995).
53. C. Kroegel, P. Julius, H. Matthys, J. C. Virchow Jr., W. Luttmann, Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts. Eur. Respir. J. 9, 899-904 (1996).
54. T. Jung, J. P. Bews, K. H. Enssle, K. Wagner, C. Neumann, C. H. Heusser, Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA. J. Immunol. Methods 217, 41-50 (1998).
55. M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, D. D. Donaldson, Interleukin-13: Central mediator of allergic asthma. Science 282, 2258-2261 (1998).
56. D. M. Walter, J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, D. T. Umetsu, Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167, 4668-4675 (2001).
57. C. Perkins, M. Wills-Karp, F. D. Finkelman, IL-4 induces IL-13-independent allergic airway inflammation. J. Allergy Clin. Immunol. 118, 410-419 (2006).
58. A. Munitz, E. B. Brandt, M. Mingler, F. D. Finkelman, M. E. Rothenberg, Distinct roles for IL-13 and IL-4 via IL-13 receptor a1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 105, 7240-7245 (2008).
59. J. D. Moffatt, What targets have knockouts revealed in asthma? Pharmacol. Ther. 107, 343-357 (2005).
60. T. R. Ramalingam, J. T. Pesce, F. Sheikh, A. W. Cheever, M. M. Mentink-Kane, M. S. Wilson, S. Stevens, D. M. Valenzuela, A. J. Murphy, G. D. Yancopoulos, J. F. Urban Jr., R. P. Donnelly, T. A.Wynn, Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor a1 chain. Nat. Immunol. 9, 25-33 (2008).
61. J. A. Johnston, L. M. Wang, E. P. Hanson, X. J. Sun, M. F. White, S. A. Oakes, J. H. Pierce, J. J. O'Shea, Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270, 28527-28530 (1995).
62. T. Yin, S. R. Keller, F. W. Quelle, B. A. Witthuhn, M. L. Tsang, G. E. Lienhard, J. N. Ihle, Y. C. Yang, Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J. Biol. Chem. 270, 20497-20502 (1995).
63. H. Xiao, T. Yin, X. Y. Wang, T. Uchida, J. Chung, M. F. White, Y. C. Yang, Specificity of interleukin-2 receptor g chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J. Biol. Chem. 277, 8091-8098 (2002).
64. S. R. Hofmann, A. Q. Lam, S. Frank, Y. J. Zhou, H. L. Ramos, Y. Kanno, D. Agnello, R. J. Youle, J. J. O'Shea, Jak3-independent trafficking of the common g chain receptor subunit: Chaperone function of Jaks revisited. Mol. Cell. Biol. 24, 5039-5049 (2004).
65. M. Chen, A. Cheng, Y. Q. Chen, A. Hymel, E. P. Hanson, L. Kimmel, Y. Minami, T. Taniguchi, P. S. Changelian, J. J. O'Shea, The amino terminus of JAK3 is necessary and sufficient for binding to the common g chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. U.S.A. 94, 6910-6915 (1997).
66. S. Zhang, C. Weinheimer, M. Courtois, A. Kovacs, C. E. Zhang, A. M. Cheng, Y. Wang, A. J. Muslin, The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 111, 833-841 (2003).
67. M. Pesu, K. Takaluoma, S. Aittomäki, A. Lagerstedt, K. Saksela, P. E. Kovanen, O. Silvennoinen, Interleukin-4-induced transcriptional activation by Stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of Stat6. Blood 95, 494-502 (2000).
68. S. Goenka, S. H. Cho, M. Boothby, Collaborator of Stat6 (CoaSt6)-Associated poly(ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription. J. Biol. Chem. 282, 18732-18739 (2007).
69. A. M. Stutz, L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr, M. Woisetschlager, The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule a gene expression by a STAT6 and CCAAT/enhancerbinding protein-dependent mechanism. J. Immunol. 170, 1789-1796 (2003).
70. S. Han, J. D. Ritzenthaler, B. Wingerd, J. Roman, Activation of peroxisome proliferatoractivated receptor b/d (PPARb/d) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/ enhancer-binding protein b. J. Biol. Chem. 280, 33240-33249 (2005).
71. M. Tomizawa, H. Saisho, Insulin-like growth factor (IGF)-II regulates CCAAT/ enhancer binding protein a expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines. J. Cell. Biochem. 102, 161-170 (2007).
72. T. I. Ceseña, T. X. Cui, G. Piwien-Pilipuk, J. Kaplani, A. A. Calinescu, J. S. Huo, J. A. Iñiguez-Lluhi, R. Kwok, J. Schwartz, Multiple mechanisms of growth hormone-regulated gene transcription. Mol. Genet. Metab. 90, 126-133 (2007).
73. N. E. King, M. E. Rothenberg, N. Zimmermann, Arginine in asthma and lung inflammation. J. Nutr. 134, 2830S-2836S; discussion 2853S (2004).
74. D. Kershenobich, F. J. Fierro, M. Rojkind, The relationship between the free pool of proline and collagen content in human liver cirrhosis. J. Clin. Invest. 49, 2246-2249 (1970).
75. J. E. Albina, J. A. Abate, B. Mastrofrancesco, Role of ornithine as a proline precursor in healing wounds. J. Surg. Res. 55, 97-102 (1993).
76. A. E. Pegg, P. P. McCann, Polyamine metabolism and function. Am. J. Physiol. 243, C212-C221 (1982).
77. C. J. Bacchi, J. Garofalo, D. Mockenhaupt, P. P. McCann, K. A. Diekema, A. E. Pegg, H. C. Nathan, E. A. Mullaney, L. Chunosoff, A. Sjoerdsma, S. H. Hutner, In vivo effects of a-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 7, 209-225 (1983).
78. W. C. Van Voorhis, Therapy and prophylaxis of systemic protozoan infections. Drugs 40, 176-202 (1990).
79. L. H. Wei, G. Wu, S. M. Morris Jr., L. J. Ignarro, Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 98, 9260-9264 (2001).
80. H. Li, C. J. Meininger, K. A. Kelly, J. R. Hawker Jr., S. M. Morris Jr., G. Wu, Activities of arginase I and II are limiting for endothelial cell proliferation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R64-R69 (2002).
81. I. N. Holcomb, R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, G. D. Frantz, D. B. Tumas, F. V. Peale Jr., D. L. Shelton, C. C. Hébert, FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4055 (2000).
82. T. Liu, S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, S. H. Phan, FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 164, 1315-1326 (2004).
83. N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, T. A. Wynn, Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 171, 3655-3667 (2003).
84. M. Owhashi, H. Maruyama, Y. Nawa, Kinetic study of eosinophil chemotactic factor production with reference to eosinophilia and granuloma formation in mice infected with Schistosoma japonicum. Int. J. Parasitol. 26, 705-711 (1996).
85. M. Owhashi, H. Arita, A. Niwa, Production of eosinophil chemotactic factor by CD8+ Tcells in Toxocara canis-infected mice. Parasitol. Res. 84, 136-138 (1998).
86. F. H. Falcone, P. Loke, X. Zang, A. S. MacDonald, R. M. Maizels, J. E. Allen, A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J. Immunol. 167, 5348-5354 (2001).
87. S. M. Russell, A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Friedmann, A. Miyajima, R. K. Puri, W. E. Paul, W. J. Leonard, Interleukin-2 receptor g chain: A functional component of the interleukin-4 receptor. Science 262, 1880-1883 (1993).
88. N. Cuesta, C. A. Salkowski, K. E. Thomas, S. N. Vogel, Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J. Immunol. 170, 5739-5747 (2003).
89. M. W. Pfaffl, A new mathematical model for relative quantification in real-Time RT-PCR. Nucleic Acids Res. 29, e45 (2001).